1. The Role of m6A Modification and m6A Regulators in Esophageal Cancer
   Yuekao Li et al, 2022, Cancers CrossRef
2. Surmounting Cancer Drug Resistance: New Perspective on RNA-Binding Proteins
   Yiyuan Feng et al, 2023, Pharmaceuticals CrossRef
3. Comprehensive analysis of N6-methyladenosine regulators with the tumor immune landscape and correlation between the insulin-like growth factor 2 mRNA-binding protein 3 and programmed death ligand 1 in bladder cancer
   Jianfeng Cui et al, 2022, Cancer Cell International CrossRef
4. Evidence for distinct mechanisms of immune suppression in EBV-positive and EBV-negative Hodgkin lymphoma
   Makka Adam et al, 2023, Journal of Clinical and Experimental Hematopathology CrossRef
5. RNA-binding protein IMP3 is a novel regulator of MEK1/ERK signaling pathway in the progression of colorectal Cancer through the stabilization of MEKK1 mRNA
   Meng Zhang et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
6. Current Pathology Model of Pancreatic Cancer
   Krzysztof Szymoński et al, 2022, Cancers CrossRef
7. IGF2BP3 Associates with Proliferative Phenotype and Prognostic Features in B-Cell Acute Lymphoblastic Leukemia
   Artturi Mäkinen et al, 2021, Cancers CrossRef
8. Prognostic and diagnostic role of PSA immunohistochemistry: A tissue microarray study on 21,000 normal and cancerous tissues
   Sarah Bonk et al, 2019, Oncotarget CrossRef
9. IMP3 Protein Overexpression Is Linked to Unfavorable Outcome in Laryngeal Squamous Cell Carcinoma
   Diana Maržić et al, 2021, Cancers CrossRef
10. Protein expression study of IMP3 in pancreatic and lung cancers: pathological and clinical correlations
    ManarA Abdel-Rahman et al, 2021, Egyptian Journal of Pathology CrossRef
11. The Expression of Insulin-Like Growth Factor 2 Messenger RNA-Binding Protein 3 in Langerhans Cell Histiocytosis and Langerhans Cell Sarcoma
    Konomi Yashige et al, 2021, The Tohoku Journal of Experimental Medicine CrossRef
12. Chromosome 15
    Harini Hariharan et al, 2023, Cancer Genes: Volume 2 CrossRef
13. Upregulation of insulin-like growth factor II mRNA-binding protein 3 (IMP3) has negative prognostic impact on early invasive (pT1) adenocarcinoma of the esophagus
    Patrick Sven Plum et al, 2018, Journal of Cancer Research and Clinical Oncology CrossRef
14. Identification of RNA-Binding Proteins as Targetable Putative Oncogenes in Neuroblastoma
    Jessica L. Bell et al, 2020, International Journal of Molecular Sciences CrossRef
15. IGF2BP3 From Physiology to Cancer: Novel Discoveries, Unsolved Issues, and Future Perspectives
    Caterina Mancarella et al, 2020, Frontiers in Cell and Developmental Biology CrossRef
16. Promising Biomarkers in Renal Cell Carcinoma
    Jada Kapoor et al, 2021, Société Internationale d’Urologie Journal CrossRef
17. Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma
    Huidi Liu et al, 2020, Frontiers in Oncology CrossRef
18. The Contributions of Cancer-Testis and Developmental Genes to the Pathogenesis of Keratinocyte Carcinomas
    Brandon Ramchatesingh et al, 2022, Cancers CrossRef
19. IMP3 Immunohistochemical Expression Is Related with Progression and Metastases in Xenografted and Cutaneous Melanomas
    Natividad Martin-Morales et al, 2024, Pathobiology CrossRef
20. Immunohistochemical Study of IMP3 Expression in Laryngeal Squamous Cell Carcinoma
    Wala’a Ahmad Al-Sayed Ashmawy et al, 2021, Open Access Macedonian Journal of Medical Sciences CrossRef
21. Patterns of TIGIT Expression in Lymphatic Tissue, Inflammation, and Cancer
    Niclas C. Blessin et al, 2019, Disease Markers CrossRef